Other languages AlloVir, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
0.798 ^USD	-1.05%		+0.11%	+17.39%

20/03	North American Morning Briefing : Markets on Hold -2-	DJ
15/03	AlloVir, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

AlloVir, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Sector Update: Health Care	23/12
AlloVir Shares Plummet as Global Trials of Anti-Viral T-Cell Therapy to be Discontinued	23/12
Top Midday Decliners	23/12
Sector Update: Health Care Stocks Gain in Late Afternoon	23/12
AlloVir scraps late-stage studies testing lead cell therapy	22/12
AlloVir scraps late-stage studies testing antiviral cell therapy	22/12
AlloVir, Inc. Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy	22/12
AlloVir to Review Strategic Alternatives for the Company and Its Portfolio of Virus-Specific T Cell Therapies	22/12
AlloVir, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
Sector Update: Health Care Stocks Declining Late Afternoon	19/23/19
Sector Update: Health Care Stocks Easing Friday Afternoon	18/23/18
Sector Update: Health Care	18/23/18
AlloVir Shares Rise After BofA Securities Cites 'Compelling Story,' Initiates Coverage With a Buy	18/23/18
AlloVir, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/23/03
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	29/23/29
AlloVir Shares Jump in Premarket Thursday After Gilead Sciences Acquires 2.93 Million Shares	29/23/29
Top Midday Decliners	23/23/23
Traders Digest Data Ahead of More Powell Comments, Driving Muted Premarket Action for US Equity Futures	22/23/22
Top Premarket Decliners	22/23/22

No results for this search